High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.9M
$2,910,080
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| PTGX |
Protagonist Therapeutics, Inc
|
Director
Other
|
2026-02-06 | $166,200 | M | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
Waddill William D.
• Director
Discretionary SellΔOwn -71.9%
2026-02-06
$1,673,600Large
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Director
Discretionary SellΔOwn -71.9%
|
2026-02-06 | $1,673,600Large | S | Form 4 |
| PTGX |
Protagonist Therapeutics, Inc
|
Director
Other
|
2025-10-10 | $83,760 | M | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
Waddill William D.
• Director
10b5-1 SellΔOwn -23.4%
2025-10-10
$979,480x2
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Director
10b5-1 SellΔOwn -23.4%
|
2025-10-10 | $979,480x2 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
Waddill William D.
• Director
10b5-1 SellΔOwn -43.8%
2025-09-22
$257,000
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
Director
10b5-1 SellΔOwn -43.8%
|
2025-09-22 | $257,000 | S | Form 4 |